Overview

Lindsay-Hemenway syndrome is a rare inherited disorder that affects both the auditory and vestibular portions of the inner ear. Individuals with this condition typically develop progressive sensorineural hearing loss together with a reduced or absent function of the balance organs. The syndrome is named after the clinicians who first described the combination of symptoms, and it is considered a type of vestibulocochlear syndrome.

Symptoms

The most common symptoms include:

• Progressive hearing loss that begins in the high frequencies and gradually affects lower frequencies.
• Difficulty understanding speech in noisy environments.
• Imbalance and unsteadiness, particularly when walking in the dark or on uneven surfaces.
• Oscillopsia, which is the sensation that the visual world moves or bounces during head movements.
• Episodic vertigo in the early stages, which may later subside as vestibular function declines.

The severity and rate of progression vary widely, even among members of the same family.

Causes

Lindsay-Hemenway syndrome is a genetic disorder. It is most often inherited in an autosomal dominant pattern, meaning that a person with one affected copy of the causative gene has a 50 percent chance of passing the condition to each child. The underlying molecular defects involve genes that are crucial for the development, maintenance, or signaling of the inner ear hair cells or the neurons that carry auditory and balance information to the brain. In many families, the specific genetic mutation has not yet been identified, and research is ongoing to better understand the pathogenic mechanisms.

Diagnosis

Diagnosis is based on a combination of clinical history, audiological assessment, and vestibular function testing. Pure-tone audiometry typically reveals bilateral sensorineural hearing loss. Vestibular testing, including video head impulse testing, caloric testing, and rotary chair testing, demonstrates reduced or absent vestibulo-ocular reflexes. Imaging studies such as magnetic resonance imaging may be performed to exclude structural lesions, tumors, or inflammatory conditions that could mimic the syndrome. Genetic testing may support the diagnosis when a known causative variant is identified.

Management

There is no cure for Lindsay-Hemenway syndrome, and no therapy has been shown to reverse the underlying degenerative process. Management focuses on maximizing function and quality of life:

• Hearing rehabilitation, including conventional hearing aids or cochlear implantation for severe to profound loss.
• Vestibular rehabilitation therapy, with customized balance exercises to improve stability and reduce fall risk.
• Use of walking aids or other assistive devices, especially in dimly lit or unfamiliar environments.
• Avoidance of aminoglycoside antibiotics and other ototoxic medications that could further damage inner ear function.
• Regular follow-up with audiology and otolaryngology specialists to monitor progression and adapt interventions.

Conclusion

Lindsay-Hemenway syndrome is a rare but important cause of combined hearing and balance disability. Early recognition is helpful in order to initiate appropriate rehabilitation, provide genetic counseling, and guide patients toward assistive technologies that can improve daily functioning. Ongoing research into the genetic basis of the condition may eventually lead to targeted therapies.